191 related articles for article (PubMed ID: 35351385)
21. Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.
Matsubara K; Otani S; Yamamoto H; Hashimoto K; Tanaka S; Shien K; Suzawa K; Miyoshi K; Yamamoto H; Okazaki M; Sugimoto S; Toyooka S
Surg Today; 2024 Apr; 54(4):317-324. PubMed ID: 37523071
[TBL] [Abstract][Full Text] [Related]
22. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction.
Wong W; Johnson B; Cheng PC; Josephson MB; Maeda K; Berg RA; Kawut SM; Harhay MO; Goldfarb SB; Yehya N; Himebauch AS
J Heart Lung Transplant; 2023 May; 42(5):669-678. PubMed ID: 36639317
[TBL] [Abstract][Full Text] [Related]
23. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
24. Association between cytomegalovirus viremia and long-term outcomes in lung transplant recipients.
Kawashima M; Ma J; Huszti E; Levy L; Berra G; Renaud-Picard B; Takahagi A; Ghany R; Sato M; Keshavjee S; Singer L; Husain S; Kumar D; Tikkanen J; Martinu T
Am J Transplant; 2024 Jun; 24(6):1057-1069. PubMed ID: 38307417
[TBL] [Abstract][Full Text] [Related]
25. Noninvasive methods for detection of chronic lung allograft dysfunction in lung transplantation.
Tian D; Huang H; Wen HY
Transplant Rev (Orlando); 2020 Jul; 34(3):100547. PubMed ID: 32498976
[TBL] [Abstract][Full Text] [Related]
26. Characterization of chronic lung allograft dysfunction phenotypes using spectral and intrabreath oscillometry.
Fu A; Vasileva A; Hanafi N; Belousova N; Wu J; Rajyam SS; Ryan CM; Hantos Z; Chow CW
Front Physiol; 2022; 13():980942. PubMed ID: 36277208
[No Abstract] [Full Text] [Related]
27. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
28. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
[TBL] [Abstract][Full Text] [Related]
29. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
[TBL] [Abstract][Full Text] [Related]
30. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
Todd JL; Jain R; Pavlisko EN; Finlen Copeland CA; Reynolds JM; Snyder LD; Palmer SM
Am J Respir Crit Care Med; 2014 Jan; 189(2):159-66. PubMed ID: 24325429
[TBL] [Abstract][Full Text] [Related]
31. Association of methacholine challenge test with diagnosis of chronic lung allograft dysfunction in lung transplant patients.
Siddiqui AS; Kumar G; Majumdar T; Graviss EA; Nguyen DT; Goodarzi A; Kaleekal T
Clin Transplant; 2018 Oct; 32(10):e13397. PubMed ID: 30192029
[TBL] [Abstract][Full Text] [Related]
32. Chronic Lung Allograft Dysfunction.
Venado A; Kukreja J; Greenland JR
Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
[TBL] [Abstract][Full Text] [Related]
33. Chronic lung allograft dysfunction subtype analysis by computed tomography volumetry.
Peräkylä LH; Raivio PM; Kesävuori RI; Piilonen AK; Stark CK; Halme MK; Nykänen AI
Clin Transplant; 2022 Jan; 36(1):e14507. PubMed ID: 34634164
[TBL] [Abstract][Full Text] [Related]
34. Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis.
Kulkarni HS; Cherikh WS; Chambers DC; Garcia VC; Hachem RR; Kreisel D; Puri V; Kozower BD; Byers DE; Witt CA; Alexander-Brett J; Aguilar PR; Tague LK; Furuya Y; Patterson GA; Trulock EP; Yusen RD
J Heart Lung Transplant; 2019 Jan; 38(1):5-16. PubMed ID: 30391193
[TBL] [Abstract][Full Text] [Related]
35. Exhaled nitric oxide after lung transplantation: impact of the native lung.
Verleden GM; Dupont LJ; Delcroix M; Van Raemdonck D; Vanhaecke J; Lerut T; Demedts M
Eur Respir J; 2003 Mar; 21(3):429-32. PubMed ID: 12661996
[TBL] [Abstract][Full Text] [Related]
36. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
37. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
[TBL] [Abstract][Full Text] [Related]
38. A new classification system for chronic lung allograft dysfunction.
Verleden GM; Raghu G; Meyer KC; Glanville AR; Corris P
J Heart Lung Transplant; 2014 Feb; 33(2):127-33. PubMed ID: 24374027
[TBL] [Abstract][Full Text] [Related]
39. The ISHLT chronic lung allograft dysfunction consensus criteria are applicable to pulmonary chronic graft-versus-host disease.
Pang Y; Charya AV; Keller MB; Sirajuddin A; Fu YP; Holtzman NG; Pavletic SZ; Agbor-Enoh S
Blood Adv; 2022 Jul; 6(14):4196-4207. PubMed ID: 35522969
[TBL] [Abstract][Full Text] [Related]
40. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]